Zentalis Pharmaceuticals Inc

The current institutional shareholding score of Zentalis Pharmaceuticals Inc is 10.00, ranking 1 out of 389 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 90.22%, representing a quarter-over-quarter increase of 37.20%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 2.73% of shares outstanding, with 0.27% increase in holdings.